Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
- PMID: 16606907
- DOI: 10.1212/01.wnl.0000215437.80053.d0
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
Abstract
Objective: To define key issues in the diagnosis of Parkinson disease (PD), to define features influencing progression, and to make evidence-based recommendations. Two clinical questions were identified: 1) Which clinical features and diagnostic modalities distinguish PD from other parkinsonian syndromes? 2) Which clinical features predict rate of disease progression?
Methods: Systematic review of the literature was completed. Articles were classified according to a four-tiered level of evidence scheme. Recommendations were based on the evidence.
Results and conclusions: 1. Early falls, poor response to levodopa, symmetry of motor manifestations, lack of tremor, and early autonomic dysfunction are probably useful in distinguishing other parkinsonian syndromes from Parkinson disease (PD). 2. Levodopa or apomorphine challenge and olfactory testing are probably useful in distinguishing PD from other parkinsonian syndromes. 3. Predictive factors for more rapid motor progression, nursing home placement, and shorter survival time include older age at onset of PD, associated comorbidities, presentation with rigidity and bradykinesia, and decreased dopamine responsiveness. Future research into methods for earlier and more accurate diagnosis of the disease and identification and clarification of predictive factors of rapid disease progression is warranted.
Comment in
-
Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2006 Dec 26;67(12):2266; author reply 2266. doi: 10.1212/01.wnl.0000252726.13187.63. Neurology. 2006. PMID: 17190966 No abstract available.
Similar articles
-
Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2006 Apr 11;66(7):976-82. doi: 10.1212/01.wnl.0000206363.57955.1b. Neurology. 2006. PMID: 16606908
-
Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2006 Dec 26;67(12):2266; author reply 2266. doi: 10.1212/01.wnl.0000252726.13187.63. Neurology. 2006. PMID: 17190966 No abstract available.
-
Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2006 Apr 11;66(7):996-1002. doi: 10.1212/01.wnl.0000215428.46057.3d. Neurology. 2006. PMID: 16606910
-
Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology. 2008 Feb 5;70(6):473-9. doi: 10.1212/01.wnl.0000299085.18976.20. Neurology. 2008. PMID: 18250292 Review.
-
Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.Neurology. 2006 Nov 14;67(9):1542-50. doi: 10.1212/01.wnl.0000243197.05519.3d. Neurology. 2006. PMID: 17101884 Review.
Cited by
-
Olfactory dysfunction in Parkinson disease.Nat Rev Neurol. 2012 May 15;8(6):329-39. doi: 10.1038/nrneurol.2012.80. Nat Rev Neurol. 2012. PMID: 22584158 Review.
-
Brief report: significant differences in perceived odor pleasantness found in children with ASD.J Autism Dev Disord. 2011 Apr;41(4):524-7. doi: 10.1007/s10803-010-1084-x. J Autism Dev Disord. 2011. PMID: 20697793
-
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: BRAZIL.Neurol Clin Pract. 2013 Dec;3(6):479-480. doi: 10.1212/01.CPJ.0000437019.37541.a2. Neurol Clin Pract. 2013. PMID: 30123691 Free PMC article. No abstract available.
-
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391. JAMA Neurol. 2014. PMID: 24711047 Free PMC article. Clinical Trial.
-
Usefulness of Olfactory Bulb Measurement in 3D-FIESTA in Differentiating Parkinson Disease from Atypical Parkinsonism.AJNR Am J Neuroradiol. 2024 Aug 9;45(8):1141-1152. doi: 10.3174/ajnr.A8275. AJNR Am J Neuroradiol. 2024. PMID: 38871365
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical